<- Go Home
MindWalk Holdings Corp.
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Market Cap
$94.2M
Volume
622.8K
Cash and Equivalents
$7.6M
EBITDA
-$16.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$9.9M
Profit Margin
60.79%
52 Week High
$4.27
52 Week Low
$1.41
Dividend
N/A
Price / Book Value
13.59
Price / Earnings
-5.44
Price / Tangible Book Value
13.59
Enterprise Value
$90.0M
Enterprise Value / EBITDA
-5.76
Operating Income
-$16.9M
Return on Equity
123.66%
Return on Assets
-36.39
Cash and Short Term Investments
$7.6M
Debt
$3.5M
Equity
$6.9M
Revenue
$16.2M
Unlevered FCF
$8.8M
Sector
Life Sciences Tools and Services
Category
N/A